Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Recent advances in stem cell technology are allowing the production of a variety of human cell types that could provide the basis for more effective drug screening for toxicity and efficacy, as well as more relevant disease modelling based on induced pluripotent stem cells derived from patients.
